Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on May 8, 2025
Guardian Recovery - Dallas Addiction Center Now In-Network with Magellan Health Insurance
EIN Presswire
·
May 8, 2025
Guardian Recovery's Dallas Addiction Center announces In-network Status With Magellan Health insurance, significantly enhancing treatment accessibility. DALLAS, TX, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Guardian Recovery's Dallas Addiction …
BAYADA Partners with Cubhub to Streamline and Scale Authorization-Based Home Care
EIN Presswire
·
May 8, 2025
Nation’s largest nonprofit home health provider selects Cubhub as exclusive EMR to unify systems, improve care, and support Medicaid scalability. FORT WORTH, TX, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Cubhub is proud to announce that it has …
A Groundbreaking Podcast Turning Up the Volume on Ovarian Cancer Awareness
EIN Presswire
·
May 8, 2025
National Ovarian Cancer Coalition launches a podcast series featuring real stories and expert insights to educate and empower those impacted by ovarian cancer. TX, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- In recognition of World Ovarian Cancer …
Breakthrough Breast Cancer Stem Cell Research Unveiled at Beljanski Integrative Cancer Conference
EIN Presswire
·
May 8, 2025
Natural compounds unveiled at major cancer conference show promise in eliminating breast cancer stem cells without harming healthy tissue AUSTIN, TX, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- A groundbreaking discovery in the fight against breast …
CodaPet launches compassionate in-home pet euthanasia services in Plano, TX, and surrounding areas.
EIN Presswire
·
May 8, 2025
The veterinarian-owned startup empowers a network of veterinarians who provide in-home euthanasia to ease the passing of pets at home, surrounded by loved ones. PLANO, TX, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- CodaPet continues to grow, now …
Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
GlobeNewswire
·
May 8, 2025
-- Company delivers on mission to transform women’s health with innovative solutions, including FemaSeed® for first-line infertility treatment and FemBloc® non-surgical permanent birth control (full system approval pending in Europe) -- ATLANTA, May 08, …
Nova Leap Health Corp. Posts Q1 2025 Results
GlobeNewswire
·
May 8, 2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 08, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is …
VitalHub Reports First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
Annual Recurring Revenue (ARR)⁽¹⁾ up 54% YoY to $73.7 million Total Revenue up 42% YoY to $21.7 million Adjusted EBITDA⁽¹⁾ up 39% YoY to $5.6 million TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: …
Tarsus to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 8, 2025
IRVINE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that management plans to participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on …
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
GlobeNewswire
·
May 8, 2025
Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 8, 2025
- Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review and pipeline reprioritization - - Promising preclinical results with STRO-004 and dual-payload ADC, as well as STRO-006 programs presented at AACR 2025 and …
Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets
GlobeNewswire
·
May 8, 2025
Pre-NDA Meeting for CTx-1301(dexmethylphenidate) Held April 2, 2025; New Drug Application Submission Targeted for Mid-2025 Non-Dilutive Funding to Accelerate Development of CTx-2103 (buspirone) KANSAS CITY, Kan., May 08, 2025 (GLOBE NEWSWIRE) -- Cingulate …
BioSyent Schedules First Quarter Earnings Release for May 15, 2025
GlobeNewswire
·
May 8, 2025
MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025 after market hours. A presentation …
Galecto Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 8, 2025
BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …
BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
GlobeNewswire
·
May 8, 2025
MELVILLE, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced …
Theriva Biologics Announces Closing of $7.5 Million Public Offering
GlobeNewswire
·
May 8, 2025
ROCKVILLE, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, …
Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 8, 2025
On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson’s disease in Q4 2025 Strengthened balance sheet with recent financing Advancing innovative POZ Platform across multiple therapeutic modalities Two new seasoned …
Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
GlobeNewswire
·
May 8, 2025
RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2025 financial results …
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Data cutoff date for Phase 2b NAVIGATE trial efficacy reached on April 30, 2025; top-line data readout expected in late June 2025 Nature Microbiology publication highlights preclinical data and the potential of CD388 as a potent, universal antiviral for …
PacBio Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2025. First quarter results: Q1 2025 Q1 2024 Revenue $37.2 million $38.8 million Instrument revenue $11.0 million …